Meredith Fisher

Meredith Fisher is a Partner at Mass General Brigham Ventures, where she focuses on early-stage life sciences investments and company creation. Previously, she served as the Director of Private Investments at Bracebridge Capital and led business development initiatives at Ginkgo BioWorks. Her earlier career includes a tenure as Senior Director at PureTech Ventures, as well as scientific roles in anti-viral drug discovery at Idenix Pharmaceuticals and Anadys Pharmaceuticals. Fisher currently holds seven board of director seats at biotechnology startups, including Mediar Therapeutics and Nocion Therapeutics, alongside two board observer roles at Scorpion Therapeutics and Amolyt. She earned a PhD from Harvard University, an MBA from the MIT Sloan School of Management, and an undergraduate degree from Mount Holyoke College. Her professional trajectory bridges foundational scientific research with institutional venture capital to support emerging healthcare enterprises.